SYBX - Synlogic Inc
Previous close
1.49
0 0%
Share volume: 632
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.49
0.00
0.00%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-11 | 2022-11-10 | 2023-03-29 | 2023-05-11 | 2023-08-10 | 2023-11-09 | 2024-03-19 | 2024-05-14 | |
Total revenue | 152.000 K | 678.000 K | 106.000 K | 174.000 K | 35.000 K | 393.000 K | 2.769 M | 8.000 K | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 152.000 K | 678.000 K | 106.000 K | 174.000 K | 35.000 K | 393.000 K | 2.769 M | 8.000 K | |
346.05% | -84.37% | 64.15% | -79.89% | 1,022.86% | 604.58% | -99.71% | |||
Operating expenses | 16.169 M | 19.012 M | 17.409 M | 16.417 M | 15.689 M | 13.016 M | 13.410 M | 10.564 M | |
Selling general and admin | 4.112 M | 4.402 M | 3.770 M | 3.967 M | 3.924 M | 3.400 M | 3.270 M | 2.884 M | |
Research and development | 12.057 M | 14.610 M | 13.639 M | 12.450 M | 11.765 M | 9.616 M | 10.140 M | 7.680 M | |
Total expenses | 16.169 M | 19.012 M | 17.409 M | 16.417 M | 15.689 M | 13.016 M | 13.410 M | 10.564 M | |
17.58% | -8.43% | -5.70% | -4.43% | -17.04% | 3.03% | -21.22% | |||
Operating income | -16.017 M | -18.334 M | -17.303 M | -16.243 M | -15.654 M | -12.623 M | -10.641 M | -10.556 M | |
Ebit | -16.017 M | -18.334 M | -17.303 M | -16.243 M | -15.654 M | -12.623 M | -10.641 M | -10.556 M | |
Pretax income | -15.842 M | -17.912 M | -16.696 M | -15.622 M | -15.039 M | -12.075 M | -14.532 M | -31.564 M | |
13.07% | -6.79% | -6.43% | -3.73% | -19.71% | 20.35% | 117.20% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 9.000 K | 3.000 K | -12.000 K | 0.000 | |
Net income basic | -15.842 M | -17.912 M | -16.696 M | -15.622 M | -15.048 M | -12.078 M | -14.520 M | -31.564 M | |
-13.07% | 6.79% | 6.43% | 3.67% | 19.74% | -20.22% | -117.38% | |||
Net income | -15.842 M | -17.912 M | -16.696 M | -15.622 M | -15.048 M | -12.078 M | -14.520 M | -31.564 M | |
-13.07% | 6.79% | 6.43% | 3.67% | 19.74% | -20.22% | -117.38% |